Keyphrases
Extremity Melanoma
100%
Regional Chemotherapy
100%
Melphalan
100%
Melanoma Model
100%
Resistance Modulation
100%
Buthionine Sulfoximine
80%
Tumor
60%
Tumor Response
60%
Tumor Growth
40%
Intra-arterial
40%
Survival Study
40%
Patient Survival
20%
Gastrointestinal
20%
Cytotoxic Effect
20%
Nude Rat
20%
Glutathione
20%
Systemic Chemotherapy
20%
Locoregional Therapy
20%
GSH Level
20%
Combined Therapy
20%
Enhanced Toxicity
20%
Tumor Patients
20%
Xenograft Model
20%
Arterial Perfusion
20%
Tumor Toxicity
20%
Tumor Growth Delay
20%
Resistance Pathways
20%
Resistance to Chemotherapy
20%
Human Xenografts
20%
Medicine and Dentistry
Regional Perfusion
100%
Melphalan
100%
Melanoma
100%
Neoplasm
80%
Buthionine Sulfoximine
80%
Tumor Progression
60%
Tumor
40%
Xenograft
20%
Antiinfective Agent
20%
Cytotoxicity
20%
Glutathione
20%
Combined Therapy
20%
Artery Perfusion
20%
Hematopoetic Toxicity
20%
Gastrointestinal Toxicity
20%
Table Salt
20%